Videos / Update on vaginal micronised progesterone soft gel capsule for unexplained threatened miscarriage
In this Product Explainer, Obstetrician and Gynaecologist Dr Hugh Porter explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (6 mins).

Weight Management in Women of Reproductive Age

New Spirometry Standards: Key Changes for Clinical Practice

Food Allergy Prevention

Protecting Young Lungs – Paediatric Insights into RSV